6OD.F ODI PHARMA AB

Healthcare Pharmaceuticals Frankfurt Exchange
0.1800 EUR
Close of Nov 11, 2026
0.0400 0.3980
Market cap
EUR 3.30M
P/E
18.0x
P/B
15.28x
ROE
83.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is 6OD.F undervalued?

Graham number

The Graham number of ODI PHARMA AB cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ODI PHARMA AB fundamental analysis

No fundamental analysis for ODI PHARMA AB yet.

ODI PHARMA AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ODI PHARMA AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products. ODI Pharma AB (publ) was founded in 2018 and is based in Stockholm, Sweden.

Full company profile